Canadian Network for Mood and Anxiety Treatments (<scp>CANMAT</scp>) and International Society for Bipolar Disorders (<scp>ISBD</scp>) 2018 guidelines for the management of patients with bipolar disorderLakshmi N. Yatham, Michael Berk, Roger S. McIntyre et al.|Bipolar Disorders|2018Cited by 1.8k
The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluationMadhukar H. Trivedi, T. Michael Kashner, A. John Rush et al.|Psychological Medicine|2004Cited by 989
The Texas Implementation of Medication AlgorithmsTrisha Suppes, Ellen B. Dennehy, Robert M. A. Hirschfeld et al.|The Journal of Clinical Psychiatry|2005Cited by 330
Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser <i>v.</i> mood stabiliser aloneMauricio Tohen, Joseph R. Calabrese, K. N. Roy Chengappa et al.|The British Journal of Psychiatry|2004Cited by 328
Report of the Texas Consensus Conference Panel on Medication Treatment of Bipolar Disorder 2000Trisha Suppes, Ellen B. Dennehy, Alan C. Swann et al.|The Journal of Clinical Psychiatry|2002Cited by 121